GlassScriptPhysician profile
Shravani Durbhakula
NPI 1447510771
$353,124.39
in general payments reported to CMS, 2019-2025
17 companies · $541 in 2025
The $541 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,348 · 2020: $572 · 2021: $108K · 2022: $237K · 2023: $1,279 · 2024: $638 · 2025: $541.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,444 · Entertainment: $15.37.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,443.69 |
| Entertainment | $15.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $343,748.54 | 2021-2022 | |
| Nevro Corp. | $5,193.91 | 2019-2023 | Senza |
| Spr Therapeutics, INC | $1,085.43 | 2023-2025 | Sprint Pns System |
| Abbott Laboratories | $750.44 | 2019-2023 | Proclaim |
| Saluda Medical Americas, INC. | $574.69 | 2023-2024 | Evoke Scs, Evoke |
| Boston Scientific Corporation | $365.15 | 2019-2023 | |
| Vertos Medical, INC. | $297.63 | 2021-2022 | |
| Medtronic, INC. | $283.70 | 2021-2023 | Vanta Adaptivestim |
| Flowonix Medical Incorporated | $245.97 | 2019-2020 | |
| Averitas Pharma INC. | $215.42 | 2023-2024 | Qutenza |
| Nalu Medical, INC. | $124.61 | 2023-2024 | Nalu Neurostimulation System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $75.19 | 2024 | Relistor |
| Camber Spine Technologies LLC | $58.30 | 2021 | |
| Collegium Pharmaceutical, INC. | $46.14 | 2024 | Belbuca |
| Abbvie INC. | $43.90 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Foundation Fusion Solutions, LLC | $15.37 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shravani Durbhakula listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.